Huapont Life Sciences Co Ltd - Asset Resilience Ratio
Huapont Life Sciences Co Ltd (002004) has an Asset Resilience Ratio of 3.68% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002004 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2024)
This chart shows how Huapont Life Sciences Co Ltd's Asset Resilience Ratio has changed over time. See net assets of Huapont Life Sciences Co Ltd for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Huapont Life Sciences Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Huapont Life Sciences Co Ltd (002004) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.08 Billion | 3.68% |
| Total Liquid Assets | CN¥1.08 Billion | 3.68% |
Asset Resilience Insights
- Limited Liquidity: Huapont Life Sciences Co Ltd maintains only 3.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Huapont Life Sciences Co Ltd Industry Peers by Asset Resilience Ratio
Compare Huapont Life Sciences Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Yangnong Chemical Co Ltd
SHG:600486 |
Agricultural Inputs | 3.65% |
|
Chengdu Wintrue Holding Co Ltd
SHE:002539 |
Agricultural Inputs | 0.11% |
|
Hubei Yihua Chemical Industry Co Ltd
SHE:000422 |
Agricultural Inputs | 0.16% |
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033 |
Agricultural Inputs | 18.19% |
|
Fanli Digital Technology Co Ltd
SHG:600228 |
Agricultural Inputs | 0.32% |
|
Insumos Agroquimicos SA
BA:INAG |
Agricultural Inputs | 1.46% |
|
Cho Bi
KO:001550 |
Agricultural Inputs | 0.00% |
|
Amoeba SA
PA:ALMIB |
Agricultural Inputs | 0.13% |
Annual Asset Resilience Ratio for Huapont Life Sciences Co Ltd (2004–2024)
The table below shows the annual Asset Resilience Ratio data for Huapont Life Sciences Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.22% | CN¥653.87 Million ≈ $95.68 Million |
CN¥29.45 Billion ≈ $4.31 Billion |
+0.17pp |
| 2023-12-31 | 2.05% | CN¥630.28 Million ≈ $92.23 Million |
CN¥30.73 Billion ≈ $4.50 Billion |
-0.30pp |
| 2022-12-31 | 2.35% | CN¥706.29 Million ≈ $103.35 Million |
CN¥30.02 Billion ≈ $4.39 Billion |
-1.08pp |
| 2021-12-31 | 3.43% | CN¥1.03 Billion ≈ $150.78 Million |
CN¥30.04 Billion ≈ $4.40 Billion |
+0.37pp |
| 2020-12-31 | 3.05% | CN¥862.27 Million ≈ $126.18 Million |
CN¥28.23 Billion ≈ $4.13 Billion |
+0.48pp |
| 2019-12-31 | 2.57% | CN¥684.89 Million ≈ $100.22 Million |
CN¥26.64 Billion ≈ $3.90 Billion |
-2.00pp |
| 2018-12-31 | 4.57% | CN¥1.21 Billion ≈ $177.50 Million |
CN¥26.55 Billion ≈ $3.89 Billion |
+4.57pp |
| 2017-12-31 | 0.00% | CN¥196.48K ≈ $28.75K |
CN¥29.09 Billion ≈ $4.26 Billion |
-6.45pp |
| 2016-12-31 | 6.45% | CN¥1.56 Billion ≈ $228.72 Million |
CN¥24.23 Billion ≈ $3.55 Billion |
+5.91pp |
| 2015-12-31 | 0.54% | CN¥107.39 Million ≈ $15.72 Million |
CN¥19.71 Billion ≈ $2.88 Billion |
+0.52pp |
| 2014-12-31 | 0.02% | CN¥2.76 Million ≈ $404.35K |
CN¥13.57 Billion ≈ $1.99 Billion |
-1.02pp |
| 2013-12-31 | 1.04% | CN¥79.20 Million ≈ $11.59 Million |
CN¥7.65 Billion ≈ $1.12 Billion |
-0.45pp |
| 2012-12-31 | 1.48% | CN¥87.90 Million ≈ $12.86 Million |
CN¥5.92 Billion ≈ $866.61 Million |
+1.47pp |
| 2010-12-31 | 0.02% | CN¥242.36K ≈ $35.46K |
CN¥1.36 Billion ≈ $198.77 Million |
-0.98pp |
| 2006-12-31 | 1.00% | CN¥7.62 Million ≈ $1.12 Million |
CN¥765.08 Million ≈ $111.96 Million |
-0.53pp |
| 2005-12-31 | 1.52% | CN¥7.28 Million ≈ $1.07 Million |
CN¥477.85 Million ≈ $69.92 Million |
+0.78pp |
| 2004-12-31 | 0.74% | CN¥3.58 Million ≈ $524.15K |
CN¥481.04 Million ≈ $70.39 Million |
-- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more